{"nct_id":"NCT05068284","title":"A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2022-01-31","start_date_type":"ACTUAL","primary_completion_date":"2023-07-20","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}